Condition

Cataract (4)

Fuchs' Endothelial Dystrophy (1)

Macular Degeneration (1)

Postoperative Complications (1)

Overall Status

Completed (3)

Recruiting (1)

Sign in for free

Phase

phase 3 (3)

early phase 1 (1)

Sponsor

Bausch & Lomb Incorporated (1)

Massachusetts Eye and Ear Infirmary (1)

Ocular Therapeutix, Inc. (1)

Southwest Oncology Group (1)

Collaborator

National Cancer Institute (NCI) (1)

National Eye Institute (NEI) (1)

Intervention

bromfenac (1)

dextenza (1)

netarsudil 0.02% ophthalmic solution (1)

placebo (1)

prednisolone (1)

selenium (1)

selenium placebo (1)

vitamin e (1)

vitamin e placebo (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Industry (2)

Other (2)

Study Type

Interventional (4)

Cataract

Showing NaN - NaN of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Cataract Trial in United States (Dextenza, Prednisolone)

Recruiting

Cataract

Aurora, Colorado
+13 more

Jan 27, 2022

Fuchs' Endothelial Dystrophy, Cataract Trial in Boston (Netarsudil 0.02% Ophthalmic Solution)

Completed

Fuchs' Endothelial Dystrophy
Cataract

Netarsudil 0.02% Ophthalmic Solution

Boston, Massachusetts

Massachusetts Eye and Ear Infirmary

Jan 24, 2021

Cataract, Macular Degeneration Trial in Boston (selenium, vitamin E, vitamin E )

Completed

Cataract
Macular Degeneration

selenium
+3 more

Boston, Massachusetts

Harvard Medical School

Aug 2, 2019

Postoperative Complications, Cataract Trial in United States (Bromfenac, Placebo)

Completed

Postoperative Complications
Cataract

Bromfenac
Placebo

Birmingham, Alabama
+38 more

Mar 13, 2013